Essential role for cyclic-AMP responsive element binding protein 1 (CREB) in the survival of acute lymphoblastic leukemia.

Autor: van der Sligte NE; Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kampen KR; Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., ter Elst A; Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Scherpen FJ; Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Meeuwsen-de Boer TG; Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Guryev V; European Research Institute for The Biology of Ageing, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van Leeuwen FN; Laboratory of Pediatric Oncology, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Kornblau SM; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America., de Bont ES; Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Publikováno v: Oncotarget [Oncotarget] 2015 Jun 20; Vol. 6 (17), pp. 14970-81.

Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.

Autor: Sie M; Department of Pediatrics, Beatrix Children's Hospital, Pediatric Oncology/Hematology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., den Dunnen WF; Department of Pathology and Medical Biology, Pathology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Lourens HJ; Department of Pediatrics, Beatrix Children's Hospital, Pediatric Oncology/Hematology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Meeuwsen-de Boer TG; Department of Pediatrics, Beatrix Children's Hospital, Pediatric Oncology/Hematology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Scherpen FJ; Department of Pediatrics, Beatrix Children's Hospital, Pediatric Oncology/Hematology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zomerman WW; Department of Pediatrics, Beatrix Children's Hospital, Pediatric Oncology/Hematology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kampen KR; Department of Pediatrics, Beatrix Children's Hospital, Pediatric Oncology/Hematology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hoving EW; Department of Neurosurgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Bont ES; Department of Pediatrics, Beatrix Children's Hospital, Pediatric Oncology/Hematology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Publikováno v: PloS one [PLoS One] 2015 Mar 23; Vol. 10 (3), pp. e0122555. Date of Electronic Publication: 2015 Mar 23 (Print Publication: 2015).

MBL2 and fever during neutropenia in children with acute lymphoblastic leukaemia.

Autor: te Poele EM, Siedlinski M, Anne de Pagter PJ, Bierings MB, Scherpen FJ, Meeuwsen-de Boer TG, Koppelman GH, Postma DS, Kamps WA, Boezen HM, de Bont ES

Publikováno v: British journal of haematology [Br J Haematol] 2012 Apr; Vol. 157 (1), pp. 132-5. Date of Electronic Publication: 2011 Nov 03.

VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms.

Autor: Roorda BD; Division of Pediatric Oncology/Hematology, Department of Pediatrics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, The Netherlands., Ter Elst A, Scherpen FJ, Meeuwsen-de Boer TG, Kamps WA, de Bont ES

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2010 Mar; Vol. 46 (5), pp. 974-82. Date of Electronic Publication: 2010 Jan 22.

The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models.

Autor: Gidding CE; Children's Cancer Center, Beatrix Children's Hospital, Groningen, The Netherlands., Germain GS, Dilling MB, Meeuwsen-de Boer TG, Ashmun RA, de Graaf SS, Veverka KA, Kamps WA, Houghton PJ

Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2000; Vol. 45 (1), pp. 21-30.